0000950170-24-045120.txt : 20240417
0000950170-24-045120.hdr.sgml : 20240417
20240417161509
ACCESSION NUMBER: 0000950170-24-045120
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240415
FILED AS OF DATE: 20240417
DATE AS OF CHANGE: 20240417
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Apeiron Investment Group Ltd.
CENTRAL INDEX KEY: 0001845711
ORGANIZATION NAME:
STATE OF INCORPORATION: O1
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40493
FILM NUMBER: 24851238
BUSINESS ADDRESS:
STREET 1: BLOCK A, APT.12
STREET 2: IL-PIAZZETTA, TOWER ROAD
CITY: SLIEMA
STATE: O1
ZIP: SLM1605
BUSINESS PHONE: 44 7557 251 563
MAIL ADDRESS:
STREET 1: BLOCK A, APT.12
STREET 2: IL-PIAZZETTA, TOWER ROAD
CITY: SLIEMA
STATE: O1
ZIP: SLM1605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Angermayer Christian
CENTRAL INDEX KEY: 0001845872
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40493
FILM NUMBER: 24851237
MAIL ADDRESS:
STREET 1: BLOCK A, APT.12
STREET 2: IL-PIAZZETTA, TOWER ROAD
CITY: SLIEMA
STATE: O1
ZIP: SLM1605
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATAI Life Sciences N.V.
CENTRAL INDEX KEY: 0001840904
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: WALLSTRASSE 16
CITY: BERLIN
STATE: 2M
ZIP: 10179
BUSINESS PHONE: (617)-699-5876
MAIL ADDRESS:
STREET 1: 524 BROADWAY
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER COMPANY:
FORMER CONFORMED NAME: ATAI Life Sciences B.V.
DATE OF NAME CHANGE: 20210115
4
1
ownership.xml
4
X0508
4
2024-04-15
0001840904
ATAI Life Sciences N.V.
ATAI
0001845711
Apeiron Investment Group Ltd.
66 & 67 BEATRICE, AMERY STREET
SILEMA
O1
SLM1707
MALTA
false
false
true
false
0001845872
Angermayer Christian
66 & 67 AMERY STREET
SILEMA
O1
SLM 1707
MALTA
false
false
true
false
false
Convertible Notes
2024-04-15
4
J
false
147950
D
Common Shares
2367200
0
I
By Apeiron Investment Group Ltd.
Convertible Notes
2024-04-15
4
J
false
147950
A
2024-04-15
2025-09-30
Common Shares
2367200
147950
I
By Apeiron Investment Group Ltd.
The conversion price for the Convertible Notes is EUR 17.00 per note.
Represents an exchange of Convertible Notes issued by ATAI Life Sciences AG for Convertible Notes issued by the Issuer with substantially similar terms and economics.
Each Convertible Note bears a notional principal amount of EUR 1.00.
The reportable securities are held by Apeiron Investment Group Ltd. ("Apeiron"). Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities.
Apeiron Investment Group Ltd. By: /s/ Julien Hoefer, Director
2024-04-17
/s/ Christian Angermayer
2024-04-17